ARTICLE | Company News
Isotechnika licenses ISA(TX)247 to Roche
April 9, 2002 7:00 AM UTC
Isotechnika (TSE:ISA) and Roche (SWX:ROCZ) will co-develop ISA's ISA(TX)247, a calcineurin inhibitor immunosuppressant in Phase II testing for renal transplantation and psoriasis. ISA said it could re...